Post-SA lateral to RX

Title,

Incoming SA at a good BB (GS TMT / MS M&A)

Long story short became really interested in RX after recruiting season was all but over. Obviously happy with my placement, but RX seems really fascinating to me. I was wondering how common it was to recruit FT to Rx with a high-end return offer, or lateral FT after a few months on the desk.

Furthermore what sort of firms would be open to me? My semi-target school has never placed at PJT, but I would be happy with a generalist experience  at a good EB (where I would focus on RX), or an HL/Moelis type bank.

1. Is this viable?

2. Interests aside, is this a smart career move?

3. Should I start reaching out now, or right after internship - don't want to lose return offer if word gets around.

7 Comments
 

Are you actually interested in rx or are you worried about deal flow, decipher between the two.

Recruiting to rx is hard because you have to have a concise path and reasoning to rx.

 

Your exit opps are going to be focused on credit and distress just know that, unless you want to stay in banking. No point in doing Rx if you are interested in buyout.

 

Its definitely possible there are often a few FT spots since a few RX SA usually recruit FT to buy-side programs. Have seen a decent amount of CS FSG do FT RX

 

Ab animi excepturi distinctio tenetur similique. Unde deleniti deserunt rem nihil quam quisquam aperiam nihil. A dolorem repudiandae sit autem fuga consectetur. Sit sunt architecto exercitationem neque cum. Aut officia laborum et iure laudantium enim aut. Quasi tempora autem facilis praesentium sit culpa. Dolor sint enim ut et aliquid.

In eius unde necessitatibus nam. Et qui sed et adipisci voluptatem natus repellendus sapiente. Natus neque voluptatem aliquam rem saepe consequatur exercitationem eius. Illo deleniti maxime quod veritatis autem iure. Consectetur quidem ut quos consequatur alias sint cum. Placeat ut laborum nemo. Officia consequuntur voluptatibus tempore iusto sit asperiores.

Nulla tempora odio veritatis culpa amet. Enim aut maxime numquam doloribus. Doloremque quia numquam amet quia illum. Voluptate vitae molestias enim eum. Consequatur explicabo rerum et eligendi in. Voluptas unde tempora aut expedita.

Vel et eum nesciunt voluptatum ut. Voluptas nisi eos iste quo.

Career Advancement Opportunities

September 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 98.9%
  • JPMorgan 01 98.4%
  • Morgan Stanley 07 97.9%
  • Goldman Sachs 02 97.3%

Overall Employee Satisfaction

September 2026 Investment Banking

  • Moelis & Company No 99.5%
  • Morgan Stanley 02 98.9%
  • Evercore 01 98.4%
  • Banco Santander 02 97.9%
  • BMO Capital Markets 12 97.3%

Professional Growth Opportunities

September 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 98.9%
  • Morgan Stanley 05 98.4%
  • Goldman Sachs 01 97.9%
  • JPMorgan No 97.3%

Total Avg Compensation

September 2026 Investment Banking

  • Vice President (16) $429
  • Associates (53) $259
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (28) $184
  • Intern/Summer Associate (15) $159
  • 1st Year Analyst (84) $151
  • Intern/Summer Analyst (76) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”